1.A Case of Autoimmune Hepatitis Combined with Graves' Disease.
Jong Hyun JHEE ; Hyun Ju KIM ; Wonseok KANG ; Sewha KIM ; Do Young KIM
The Korean Journal of Gastroenterology 2015;65(1):48-51
A 25-year-old woman presented with jaundice, palpitation, and weight loss of 5 kg during a period of 2 weeks. Laboratory tests showed elevated levels of liver enzymes (AST 1,282 IU/L, ALT 1,119 IU/L) and total bilirubin (6.4 mg/dL); negative for hepatitis virus infection; elevated serum levels of triiodothyronine (T3, 3.60 ng/dL), free thyroxine (fT4, 3.82 ng/dL), and lowered serum level of thyroid stimulating hormone (TSH, <0.025 microIU/mL); and positive for thyroid stimulating antibody and anti-mitochondrial antibody (AMA). The liver biopsy findings were consistent with autoimmune hepatitis (AIH). Accordingly, oral steroid therapy was started with 60 mg of prednisolone under the impression of AIH associated with Graves' disease. After a week of steroid therapy, the clinical manifestation showed significant improvement, with normalization of both liver and thyroid functions. Diagnosis of the liver condition of patients who present with hyperthyroidism and liver dysfunction is important, so that appropriate therapy can be promptly initiated.
Adult
;
Alanine Transaminase/analysis
;
Antibodies, Antinuclear/blood
;
Aspartate Aminotransferases/analysis
;
Bilirubin/blood
;
Female
;
Graves Disease/complications/*diagnosis/drug therapy
;
Hepatitis, Autoimmune/complications/*diagnosis/drug therapy
;
Humans
;
Immunoglobulins, Thyroid-Stimulating/blood
;
Liver/enzymology/metabolism/pathology
;
Prednisolone/therapeutic use
;
Steroids/therapeutic use
;
Thyrotropin/blood
2.The effect of periodontal flap surgery on Matrix metalloproteinases (MMPs) and Tissue inhibitors of matrix metalloproteinase-1 (TIMP-1) levels in gingival crevicular fluids of periodontitis patients.
Jhee Hyun KIM ; Jea Seung KO ; Hyun Man KIM ; Tae Il KIM ; Yang Jo SEOL ; Yong Moo LEE ; Young KU ; Chong Pyoung CHUNG ; Soo Boo HAN ; In Chul RHYU
The Journal of the Korean Academy of Periodontology 2005;35(1):123-132
No abstract available.
Gingival Crevicular Fluid*
;
Humans
;
Matrix Metalloproteinase 1*
;
Matrix Metalloproteinases*
;
Periodontitis*
3.Machine Learning-assisted Quantitative Mapping of Intracortical Axonal Plasticity Following a Focal Cortical Stroke in Rodents
Hyung Soon KIM ; Hyo Gyeong SEO ; Jong Ho JHEE ; Chang Hyun PARK ; Hyang Woon LEE ; Bumhee PARK ; Byung Gon KIM
Experimental Neurobiology 2023;32(3):170-180
Stroke destroys neurons and their connections leading to focal neurological deficits. Although limited, many patients exhibit a certain degree of spontaneous functional recovery. Structural remodeling of the intracortical axonal connections is implicated in the reorganization of cortical motor representation maps, which is considered to be an underlying mechanism of the improvement in motor function. Therefore, an accurate assessment of intracortical axonal plasticity would be necessary to develop strategies to facilitate functional recovery following a stroke. The present study developed a machine learning-assisted image analysis tool based on multi-voxel pattern analysis in fMRI imaging. Intracortical axons originating from the rostral forelimb area (RFA) were anterogradely traced using biotinylated dextran amine (BDA) following a photothrombotic stroke in the mouse motor cortex. BDA-traced axons were visualized in tangentially sectioned cortical tissues, digitally marked, and converted to pixelated axon density maps. Application of the machine learning algorithm enabled sensitive comparison of the quantitative differences and the precise spatial mapping of the post-stroke axonal reorganization even in the regions with dense axonal projections. Using this method, we observed a substantial extent of the axonal sprouting from the RFA to the premotor cortex and the peri-infarct region caudal to the RFA. Therefore, the machine learningassisted quantitative axonal mapping developed in this study can be utilized to discover intracortical axonal plasticity that may mediate functional restoration following stroke.
4.Impact of body mass index on survival in patients undergoing peritoneal dialysis: Analysis of data from the Insan Memorial End-Stage Renal Disease Registry of Korea (1985–2014)
Seun Deuk HWANG ; Jin Ho LEE ; Jong Hyun JHEE ; Joon Ho SONG ; Joong Kyung KIM ; Seoung Woo LEE
Kidney Research and Clinical Practice 2019;38(2):239-249
BACKGROUND: Significant increases in the prevalence of obesity have been observed among patients with peritoneal dialysis (PD). The impact of body mass index (BMI) on survival remains unknown in Korean PD patients. METHODS: Among data of 80,674 patients on PD acquired from the Insan Memorial ESRD Registry database for the years 1985 to 2014, 6,071 cases were analyzed. Subjects were classified by baseline BMI; < 21.19 kg/m² (quartile 1, n = 1,518), 21.19 to 23.18 kg/m² (quartile 2, reference; n = 1,453), 23.19 to 25.71 kg/m² (quartile 3, n = 1,583), and > 25.71 kg/m² (quartile 4, n = 1,517). RESULTS: Mean age was 65.8 years, and baseline BMI was 23.57 kg/m². Numbers of male and diabetic patients were 3,492 (57.5%) and 2,192 (36.1%), respectively. Among 6,071 cases, 2,229 (36.7%) all-cause deaths occurred. As a whole, Kaplan–Meier survival curves according to BMI quartiles was significantly different (P = 0.001). All-cause mortality was significantly higher in quartile 4 than in the reference (hazard ratio [HR] = 1.154, 95% confidence interval [CI], 1.025–1.300; P = 0.018). There was no statistical difference in all-cause mortality among BMI quartiles in diabetic patients on PD. In non-diabetic patients, all-cause mortality of quartiles 1 and 3 was not different from the reference, but the HR was 1.176 times higher in quartile 4 (95% CI, 1.024–1.350; P = 0.022). CONCLUSION: Baseline BMI > 25.71 kg/m² seems to be an important risk factor for all-cause mortality in Korean PD patients.
Body Mass Index
;
Diabetes Mellitus
;
Humans
;
Kidney Failure, Chronic
;
Korea
;
Male
;
Mortality
;
Obesity
;
Peritoneal Dialysis
;
Prevalence
;
Risk Factors
5.Body mass index is inversely associated with mortality in patients with acute kidney injury undergoing continuous renal replacement therapy.
Hyoungnae KIM ; Joohwan KIM ; Changhwan SEO ; Misol LEE ; Min Uk CHA ; Su Young JUNG ; Jong Hyun JHEE ; Seohyun PARK ; Hae Ryong YUN ; Youn Kyung KEE ; Chang Yun YOON ; Hyung Jung OH ; Jung Tak PARK ; Tae Ik CHANG ; Tae Hyun YOO ; Shin Wook KANG ; Seung Hyeok HAN
Kidney Research and Clinical Practice 2017;36(1):39-47
BACKGROUND: Many epidemiologic studies have reported on the controversial concept of the obesity paradox. The presence of acute kidney injury (AKI) can accelerate energy-consuming processes, particularly in patients requiring continuous renal replacement therapy (CRRT). Thus, we aimed to investigate whether obesity can provide a survival benefit in this highly catabolic condition. METHODS: We conducted an observational study in 212 patients who had undergone CRRT owing to various causes of AKI between 2010 and 2014. The study end point was defined as death that occurred within 30 days after the initiation of CRRT. RESULTS: Patients were categorized into three groups according to tertiles of body mass index (BMI). During ≥30 days after the initiation of CRRT, 39 patients (57.4%) in the highest tertile died, as compared with 58 patients (78.4%) in the lowest tertile (P = 0.02). In a multivariable analysis adjusted for cofounding factors, the highest tertile of BMI was significantly associated with a decreased risk of death (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.37–0.87; P = 0.01). This significant association remained unaltered for 60-day (HR, 0.64; 95% CI, 0.43–0.94; P = 0.03) and 90-day mortality (HR, 0.66; 95% CI, 0.44–0.97; P = 0.03). CONCLUSION: This study showed that a higher BMI confer a survival benefit over a lower BMI in AKI patients undergoing CRRT.
Acute Kidney Injury*
;
Body Mass Index*
;
Epidemiologic Studies
;
Humans
;
Mortality*
;
Obesity
;
Observational Study
;
Renal Replacement Therapy*
6.Cumulative fluid balance and mortality in elderly patients with acute kidney injury requiring continuous renal-replacement therapy: a multicenter prospective cohort study
Jong Hyun JHEE ; Jae Yoon PARK ; Jung Nam AN ; Dong Ki KIM ; Kwon Wook JOO ; Yun Kyu OH ; Chun Soo LIM ; Yon Su KIM ; Seung Hyeok HAN ; Tae-Hyun YOO ; Shin-Wook KANG ; Jung Pyo LEE ; Jung Tak PARK
Kidney Research and Clinical Practice 2020;39(4):414-425
Background:
The effect of fluid balance on outcomes in elderly patients with acute kidney injury (AKI) requiring continuous renal-replacement therapy (CRRT) is not explained well. We investigated outcomes according to cumulative fluid balance (CFB) in elderly patients with AKI undergoing CRRT.
Methods:
A total of 607 patients aged 65 years or older who started CRRT due to AKI were enrolled and stratified into two groups (fluid overload [FO] vs. no fluid overload [NFO]) based on the median CFB value for 72 hours before CRRT initiation. Propensity score-matching analysis was performed.
Results:
The median age of included patients was 73.0 years and 60.0% of the population was male. The median 72-hour CFB value was 2,839.0 mL. The overall cumulative survival and 28-day survival rates were lower in the FO group than in the NFO group (P < 0.001 for both) and remained so after propensity score-matching. Furthermore, patients in the FO group demonstrated a higher overall mortality risk after adjustment for age, sex, systolic blood pressure, Charlson comorbidity index, Acute Physiology and Chronic Health Evaluation II score, serum albumin, creatinine, diuretic use, and mechanical ventilation status (hazard ratio, 1.38; 95% confidence interval, 1.13 to 1.89; P < 0.001). Among survivors, both the duration of CRRT and the total duration of hospitalization from CRRT initiation showed no difference between the FO and NFO groups.
Conclusion
A higher CFB value is associated with an increased risk of mortality in elderly patients with AKI requiring CRRT.
7.Cumulative fluid balance and mortality in elderly patients with acute kidney injury requiring continuous renal-replacement therapy: a multicenter prospective cohort study
Jong Hyun JHEE ; Jae Yoon PARK ; Jung Nam AN ; Dong Ki KIM ; Kwon Wook JOO ; Yun Kyu OH ; Chun Soo LIM ; Yon Su KIM ; Seung Hyeok HAN ; Tae-Hyun YOO ; Shin-Wook KANG ; Jung Pyo LEE ; Jung Tak PARK
Kidney Research and Clinical Practice 2020;39(4):414-425
Background:
The effect of fluid balance on outcomes in elderly patients with acute kidney injury (AKI) requiring continuous renal-replacement therapy (CRRT) is not explained well. We investigated outcomes according to cumulative fluid balance (CFB) in elderly patients with AKI undergoing CRRT.
Methods:
A total of 607 patients aged 65 years or older who started CRRT due to AKI were enrolled and stratified into two groups (fluid overload [FO] vs. no fluid overload [NFO]) based on the median CFB value for 72 hours before CRRT initiation. Propensity score-matching analysis was performed.
Results:
The median age of included patients was 73.0 years and 60.0% of the population was male. The median 72-hour CFB value was 2,839.0 mL. The overall cumulative survival and 28-day survival rates were lower in the FO group than in the NFO group (P < 0.001 for both) and remained so after propensity score-matching. Furthermore, patients in the FO group demonstrated a higher overall mortality risk after adjustment for age, sex, systolic blood pressure, Charlson comorbidity index, Acute Physiology and Chronic Health Evaluation II score, serum albumin, creatinine, diuretic use, and mechanical ventilation status (hazard ratio, 1.38; 95% confidence interval, 1.13 to 1.89; P < 0.001). Among survivors, both the duration of CRRT and the total duration of hospitalization from CRRT initiation showed no difference between the FO and NFO groups.
Conclusion
A higher CFB value is associated with an increased risk of mortality in elderly patients with AKI requiring CRRT.
8.Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management ofhyponatremia
Yeonhee LEE ; Kyung Don YOO ; Seon Ha BAEK ; Yang Gyun KIM ; Hyo Jin KIM ; Ji Young RYU ; Jin Hyuk PAEK ; Sang Heon SUH ; Se Won OH ; Jeonghwan LEE ; Jong Hyun JHEE ; Jin-Soon SUH ; Eun Mi YANG ; Young Ho PARK ; Yae Lim KIM ; Miyoung CHOI ; Kook-Hwan OH ; Sejoong KIM ;
Kidney Research and Clinical Practice 2022;41(4):393-411
The Korean Society for Electrolyte and Blood Pressure Research, in collaboration with the Korean Society of Nephrology, has published a clinical practice guideline (CPG) document for hyponatremia treatment. The document is based on an extensive evidence-based review of the diagnosis, evaluation, and treatment of hyponatremia with the multidisciplinary participation of representative experts in hyponatremia with methodologist support for guideline development. This CPG consists of 12 recommendations (two for diagnosis, eight for treatment, and two for special situations) based on eight detailed topics and nine key questions. Each recommendation begins with statements graded by the strength of the recommendations and the quality of the evidence. Each statement is followed by rationale supporting the recommendations. The committee issued conditional recommendations in favor of rapid intermittent bolus administration of hypertonic saline in severe hyponatremia, the use of vasopressin receptor antagonists in heart failure with hypervolemic hyponatremia, and syndrome of inappropriate antidiuresis with moderate to severe hyponatremia, the individualization of desmopressin use, and strong recommendation on the administration of isotonic fluids as maintenance fluid therapy in hospitalized pediatric patients. We hope that this CPG will provide useful recommendations in practice, with the aim of providing clinical support for shared decision-making to improve patient outcomes.
9.Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia
Yeonhee LEE ; Kyung Don YOO ; Seon Ha BAEK ; Yang Gyun KIM ; Hyo Jin KIM ; Ji Young RYU ; Jin Hyuk PAEK ; Sang Heon SUH ; Se Won OH ; Jeonghwan LEE ; Jong Hyun JHEE ; Jin-Soon SUH ; Eun Mi YANG ; Young Ho PARK ; Yae Lim KIM ; Miyoung CHOI ; Kook-Hwan OH ; Sejoong KIM ;
The Korean Journal of Internal Medicine 2022;37(6):1120-1137
The Korean Society for Electrolyte and Blood Pressure Research, in collaboration with the Korean Society of Nephrology, has published a clinical practice guideline (CPG) document for hyponatremia treatment. The document is based on an extensive evidence-based review of the diagnosis, evaluation, and treatment of hyponatremia with the multidisciplinary participation of representative experts in hyponatremia with methodologist support for guideline development. This CPG consists of 12 recommendations (two for diagnosis, eight for treatment, and two for special situations) based on eight detailed topics and nine key questions. Each recommendation begins with statements graded by the strength of the recommendations and the quality of the evidence. Each statement is followed by rationale supporting the recommendations. The committee issued conditional recommendations in favor of rapid intermittent bolus administration of hypertonic saline in severe hyponatremia, the use of vasopressin receptor antagonists in heart failure with hypervolemic hyponatremia, and syndrome of inappropriate antidiuresis with moderate to severe hyponatremia, the individualization of desmopressin use, and strong recommendation on the administration of isotonic fluids as maintenance fluid therapy in hospitalized pediatric patients. We hope that this CPG will provide useful recommendations in practice, with the aim of providing clinical support for shared decision-making to improve patient outcomes.
10.Intensity of statin therapy and renal outcome in chronic kidney disease: Results from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease
Jong Hyun JHEE ; Young Su JOO ; Jung Tak PARK ; Tae-Hyun YOO ; Sue Kyung PARK ; Ji Yong JUNG ; Soo Wan KIM ; Yun Kyu OH ; Kook-Hwan OH ; Shin-Wook KANG ; Kyu Hun CHOI ; Curie AHN ; Seung Hyeok HAN
Kidney Research and Clinical Practice 2020;39(1):93-102
Background:
Higher statin intensity is associated with a lower risk of mortality in patients with cardiovascular disease. However, little is known about the relationship between statin intensity and chronic kidney disease (CKD) progression.
Methods:
We studied whether statin intensity affects kidney function decline in 1,073 patients from the Korean Cohort Study for Outcome in Patients With Chronic Kidney Disease. The participants were classified based on statin intensity as low, moderate, and high. The study endpoint was CKD progression (composite of doubling of serum creatinine, ≥ 50% decrease in estimated glomerular filtration rate [eGFR] from baseline, or end-stage renal disease).
Results:
The mean age was 56.0 ± 11.4 years, and 665 (62.0%) participants were male. The mean eGFR was 51.7 ± 26.7 mL/min/1.73 m2; there were no differences in baseline eGFR among statin intensity groups. During the median follow-up of 39.9 (25.4-61.6) months, 255 (23.8%) patients reached the study endpoint. In multivariable Cox model after adjustment of confounders, the hazard ratios (95% confidence interval) for adverse kidney outcome were 0.97 (0.72-1.30) and 1.15 (0.60-2.20) in moderate and high statin intensity groups, respectively, compared with the low intensity group. In addition, no significant association was observed in subgroups stratified by age, sex, eGFR, and atherosclerotic cardiovascular disease risk scores.
Conclusion
We did not observe any significant association between intensity of statin therapy and progression of CKD. Long-term kidney outcomes may not be affected by statin intensity.